The dates and venue for the upcoming Hematology event will be announced shortly.
For further details, Please contact us at secretary@magnusmeetings.com or call + 1 (702) 988 2320.
Hematology is the branch of medicine that deals with blood and bone marrow abnormalities, such as anaemia, coagulation problems, and malignancies like leukaemia. Pharmacometrics and quantitative systems pharmacology (QSP) are increasingly being employed in model-informed drug discovery and development (MID3) of new haematological medications, as well as clinical tools to improve the efficacy of existing therapies. More than a century ago, the linkages between quantitative pharmacology and haematology were identified. Since it is often predicted to be enhanced over the years and years, the entire market for haematological medications is at a high point. From 2015 to 2021, the haematology sedate and expressive market is expected to grow at a rate of 7.5 percent, according to the overall market master.
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan Lluis Vives Corrons, Institute for Leukaemia Research Josep Carreras, Spain
Title : Histologic transformation of mantle zone lymphoma to diffuse large B-Cell lymphoma: A case report of disease relapse after Covid-19 infection
Lilija Bancevica, Riga Stradins University, Latvia
Title : Improving outcomes of curable lymphoma in resource constrained regions
Reena Nair, TATA Medical Centre, India
Title : Covid-19 and erythrocyte groups
Marina Nagervadze, Batumi Shota Rustaveli State University, Georgia
Title : Achieving 100% blood traceability compliance: A United Kingdom district hospital experience
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom
Title : Role of erythrocytapheresis in sickle cell anemia crisis management: A tertiary care centre experience from Chhattisgarh state of central India
Neelesh Jain, Transfusion Medicine at Balco Medical Centre, India